Clinical Trials Logo

Clinical Trial Summary

From patient charts we will review patients who had undergone cesarean section within the last 6 months and identify those who received a The Hayman uterine compression suture for uterine atony. We will also select patients who delivered a baby without recieving a Hayman suture to create a control group. Patietns will be grouped as Hayman Group if they recevied a Hayman suture during C/S and control group if thay had not recevied a Hayman suture. We will then check patient charts for post-cesarean outpatient clinic visit and select those who received ovarian reserve evaluation via hormones and antral follicle count during the visits. Finally, we are planning to investigate any correlation between Hayman suture and ovarian dysfunction.


Clinical Trial Description

Hayman suture is a common technique for uterine compression to stop bleeding due to uterine atony. Hayman described placement of two to four vertical compression sutures from the anterior to posterior uterine wall without hysterectomy. It is usually employed to overcome uterine atoy dıring cesarean section. However, since the technique is relatively new, data on its safety and efficacy arelimited to a few case reports. several complications including cavity obliteration, blood entrapment and infections have been described. However, data regarding the ovarioan function is lacking. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03930407
Study type Observational
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact Aysu Akca, MD
Phone +905053868637
Email aysuakca4@gmail.com
Status Recruiting
Phase
Start date April 15, 2019
Completion date June 15, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06219538 - DAISY Uterine Drain Device Evaluation N/A
Completed NCT03959436 - Database Evaluating Outcomes of Using Carbetocin as the Primary Uterotonic Following Cesarean Delivery
Completed NCT03867383 - Calcium Chloride for Prevention of Uterine Atony During Cesarean Phase 1/Phase 2
Withdrawn NCT03361124 - Oxytocin Dosing at Planned Cesarean Section and Anemia Phase 4
Completed NCT03904446 - Multimodal Uterotonics at the Time of Cesarean Section in Laboring Patients Phase 4
Completed NCT06353074 - Uterine Preservation With Acar's Atony Suture for Postpartum Uterine Hemorrhage
Completed NCT05027048 - Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery Phase 3
Recruiting NCT04833556 - Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery